Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3%

Pharmaceutical stocks came under pressure on Wednesday after US President Donald Trump unveiled a phased tariff plan for imported generic medicines, raising concerns over the long-term outlook for one of the industry’s biggest export markets.The sell-off came even though the proposal gives generic drugmakers a two-year tariff-free window before steep duties are introduced. Nifty Pharma…

Read Full News

Trump announces 0% tariff on generic medicines for two years; 200% thereafter

Trump said the move was intended to encourage companies to manufacture generic medicines domestically US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years and then steep tariff hikes aimed at bringing pharmaceutical manufacturing back to the…

Read Full News

Stock Market Today Highlights: Sensex ends over 230 points down; Nifty slips below 24,200

Sensex falls 443 points as HDFC Bank, Axis Bank drag markets lower Benchmark equity indices ended lower on Monday, weighed down by sharp losses in HDFC Bank and Axis Bank following their quarterly earnings, while renewed US-Iran tensions also dampened investor sentiment. The BSE Sensex fell 442.93 points, or 0.57%, to close at 77,708.52 after…

Read Full News

Donald Trump Tariffs: Donald Trump’s tariff tornado returns as India deal stalls

File photo: US President Donald Trump speaks during an event to announce new tariffs on April 2, 2025, in Washington (Picture credit: AP) TOI correspondant from Washington: MAGA boss Donald Trump is preparing to unleash yet another wave of tariffs on dozens of countries, including India, within days, doubling down on his favorite economic weapon…

Read Full News

India Trade Policy Reforms: India’s growth remains strong, but trade barriers threaten 2047 goal: WTO

India will need to address structural challenges such as high trade costs, regulatory complexity, infrastructure gaps and barriers to deeper global integration if it is to achieve its ambition of becoming a developed nation by 2047, according to the World Trade Organisation’s (WTO) latest Trade Policy Review (TPR) report.The report said India remained the fastest-growing…

Read Full News
Translate »